Live Chat
Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Jean L. Wright, editor.
    Summary: This book is a comprehensive guide to breast toxicity. Adjuvant radiation remains standard for a majority of women who undergo breast-conserving surgery for breast cancer, and indications for post-mastectomy and regional lymph node irradiation have also broadened with recent publications. At the same time, locoregional recurrence has declined and survival has improved in recent decades. In the current era of excellent breast cancer outcomes, then, considering the balance between toxicity and outcomes becomes paramount. Several recent editorials recommend considering toxicity against the potential benefit of adjuvant radiation in tailoring radiation decisions for individual patients. Thus, a clear understanding of the potential toxicities of adjuvant radiation for breast cancer is critical to optimizing outcomes in modern breast cancer management. Here, authors have collected recent data focused on toxicity of treatment that provide an opportunity for improving this optimization. Chapters cover both acute and late toxicity of radiation for breast cancer, including tailored risk assessment for each of these potential toxicities, considerations for including risk of toxicity in management decisions, and toxicity management strategies. This is an ideal guide for radiation oncologists, residents, and oncologists seeking to optimize care for their patients. .
    Digital Access Springer 2019
  • Book
    guest editors, S.N. Eisenstadt, Ilana Friedrich Silber.
    Print 1988
  • Article
    Haegert DG, Hurd C, Coombs RR.
    Immunology. 1978 Mar;34(3):533-8.
    Comparisons were made between the Direct Antiglobulin Rosetting Reaction (DARR) and Direct Immunofluorescence (DIF) in the detection of surface membrane immunoglobulin of human peripheral lymphocytes. The DARR was more sensitive and the results with this testing procedure (as opposed to those with the DIF) were not influenced by various treatments of the lymphocytes before testing, such as incubation in AB serum at +/- 4 degrees, incubation in serum-free medium at 37 degrees or short exposure to acetate buffer at pH 4.0. Again the DARR (as opposed to the DIF) gave essentially the same results whether the red cell-linked antiglobulin was IgG or the F(ab')2 preparation. With mixed rosetting for both T and SmIg+/- lymphocytes, there was only 1% or less null cells and only 5% or less lymphocytes rosetted with both marker red cells.
    Digital Access Access Options